Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.56 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.55 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 4/20 | 0.48 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.46 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.44 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.44 |
| ▸ | PAM | P19021 | 2/20 | 0.42 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.40 |
| ▸ | GABRP | O00591 | 1/20 | 0.40 |
| ▸ | GABRD | O14764 | 1/20 | 0.40 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.40 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.40 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.40 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10757164 | 0.95 | LMNA (0.55) | TSHRSLC22A6CAMK2ALMNANFKB1 | |
| SCHEMBL4079049 | 0.89 | TSHR (0.48) | TSHRLMNAPAMCYP1A2KMT2A | |
| SCHEMBL638360 | 0.87 | TSHR (0.43) | TSHRSLC22A6CAMK2ALMNANFKB1 | |
| SCHEMBL1237232 | 0.84 | LMNA (0.50) | TSHRSLC22A6CAMK2ALMNANFKB1 | |
| SCHEMBL9558119 | 0.84 | SLC22A6 (0.61) | TSHRSLC22A6CAMK2ALMNANFKB1 | |
| SCHEMBL13224338 | 0.84 | DGKA (0.48) | TSHRLMNAPAMCYP1A2KMT2A | |
| SCHEMBL2869946 | 0.82 | TSHR (0.58) | TSHRSLC22A6CAMK2ALMNANFKB1 | |
| SCHEMBL29231823 | 0.81 | DGKA (0.52) | TSHRLMNAPAMCYP1A2KMT2A | |
| SCHEMBL4953488 | 0.81 | TSHR (0.52) | TSHRSLC22A6CAMK2ALMNANFKB1 | |
| SCHEMBL4669422 | 0.80 | TSHR (0.56) | TSHRSLC22A6CAMK2ALMNANFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114280189-B | Method for quickly and quantitatively analyzing fermentation metabolites of microbial cell factory | 大连理工大学 | 2022-09-09 | — | — | CN | claimed |
| CN-114561312-B | Recombinant yeast for synthesizing ursolic acid and construction method thereof | 北京理工大学 | 2022-08-09 | — | — | CN | claimed |
| CN-114561312-A | Recombinant yeast for synthesizing ursolic acid and construction method thereof | 北京理工大学 | 2022-05-31 | — | — | CN | claimed |
| CN-112795495-B | Method for producing heterologous cannabichromene by using saccharomyces cerevisiae | 大连理工大学 | 2021-10-26 | — | — | CN | claimed |
| CN-112795495-A | Method for producing heterologous cannabichromene by using saccharomyces cerevisiae | 大连理工大学 | 2021-05-14 | — | — | CN | claimed |
| CN-122038157-A | Engineering bacteria and method for synthesizing lacrimal alcohol | 天津凯莱英生物科技有限公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-119020170-B | Monascus purpureus and application of selenium-enriched monascus prepared by same | 西北大学 | 2025-06-10 | — | — | CN | disclosed |
| CN-119269659-A | Application of urine organic acid in health management | 欧湧淳 | 2025-01-07 | — | — | CN | disclosed |
| CN-119020170-A | Monascus purpureus and application of selenium-enriched monascus prepared by same | 西北大学 | 2024-11-26 | — | — | CN | disclosed |
| CN-118726121-A | Recombinant pichia pastoris strain, construction method and application thereof | 中国科学院大连化学物理研究所 | 2024-10-01 | — | — | CN | disclosed |
| CN-113930348-B | Yarrowia lipolytica engineering strain for biosynthesis of glycyrrhetinic acid by taking glucose as substrate, construction and application thereof | 河北维达康生物科技有限公司 | 2024-07-12 | — | — | CN | disclosed |
| CN-114958625-B | Culture and preservation method of aspergillus terreus for producing lovastatin by fermentation | 福安药业集团烟台只楚药业有限公司 | 2023-12-19 | — | — | CN | disclosed |
| WO-2009115652-A2 | COMPOSITION AND METHODS USED DURING ANTI-HIV TREATMENT | UNIVERSITE DE LA MEDITERANNEE, AIX-MARSEILLE II (FR) | 2009-09-24 | — | — | WO | disclosed |
| WO-2009112653-A2 | COSMETIC AND/OR DERMATOLOGICAL COMPOSITION | UNIVERSITE DE LA MEDITERRANEE, AIX-MARSEILLE II (FR) | 2009-09-17 | — | — | WO | disclosed |
| US-20090099151-A1 | Modified Release Pharmaceutical Compositions and Processes Thereof | PANACEA BIOTEC LTD. (IN) | 2009-04-16 | — | — | US | disclosed |
| EP-2034985-A1 | COMBINATION OF AN HMG-COA REDUCTASE INHIBITOR AND A FARNESYL-PYROPHOSPHATASE SYNTHASE INHIBITOR FOR THE TREATMENT OF DISEASES RELATED TO THE PERSISTENCE AND/OR ACCUMULATION OF PRENYLATED PROTEINS | Université de la Méditerranée - Aix-Marseille II (FR) | 2009-03-18 | — | — | EP | disclosed |
| EP-1906932-A2 | MODIFIED RELEASE PHARMACEUTICAL COMPOSITIONS ON THE BASIS OF TWO POLYMERS AND PROCESSES THEREOF | Panacea Biotec Ltd. (IN) | 2008-04-09 | — | — | EP | disclosed |
| WO-2008003864-A1 | COMBINATION OF AN HMG-COA REDUCTASE INHIBITOR AND A FARNESYL-PYROPHOSPHATASE SYNTHASE INHIBITOR FOR THE TREATMENT OF DISEASES RELATED TO THE PERSISTENCE AND/OR ACCUMULATION OF PRENYLATED PROTEINS | UNIVERSITE DE LA MEDITERRANEE AIX-MARSEILLE II (FR) | 2008-01-10 | — | — | WO | disclosed |
| WO-2007000778-A2 | MODIFIED RELEASE PHARMACEUTICAL COMPOSITIONS ON THE BASIS OF TWO POLYMERS AND PROCESSES THEREOF | PANACEA BIOTEC LTD. (IN) | 2007-01-04 | — | — | WO | disclosed |
| US-4470981-A | STEROIDS, LOWERING SERUM CHOLESTEROL | HESSE ROBERT H | 1984-09-11 | — | — | US | disclosed |